Croup Management and Anesthesia Considerations

Croup, a common respiratory illness in young children, is typically a self-limited viral infection that causes inflammation of the upper airway, including the larynx and subglottic region. While mild cases are often managed with supportive care, moderate to severe croup requires a more structured medical intervention, including medications to reduce inflammation and airway obstruction. In rare cases, croup can lead to significant airway compromise, necessitating specialized anesthesia considerations, especially when airway interventions such as intubation are required.

General Management of Croup

The treatment of croup depends on the severity of the condition, which is often assessed using the Westley Croup Score. This scoring system helps guide management by evaluating factors such as stridor, retractions, cyanosis, level of consciousness, and air entry. Based on the score, croup is classified into mild, moderate, and severe categories, with corresponding treatment strategies.

Mild croup (Westley score ≤2) is usually treated on an outpatient basis with supportive care, including hydration, fever control with antipyretics, and a single dose of corticosteroids like dexamethasone. Dexamethasone at a dose of 0.6 mg/kg orally is commonly administered due to its long duration of action and ability to reduce airway inflammation effectively. The benefit of dexamethasone in reducing the severity of symptoms, minimizing the need for return medical visits, and shortening the course of the illness is well-documented. For milder cases, observation is often brief, and patients can be discharged home with instructions for close monitoring by caregivers.

Moderate to severe croup (Westley score ≥3) requires more intensive treatment. In addition to dexamethasone, children with moderate or severe croup are administered nebulized epinephrine. Epinephrine reduces subglottic edema through vasoconstriction, providing rapid relief from airway obstruction. Racemic epinephrine (0.5 mL per kg of a 1:1000 solution) or L-epinephrine can be used, with L-epinephrine demonstrating longer-lasting effects in some studies. However, the effects of epinephrine are temporary, and rebound symptoms can occur after a few hours, necessitating a period of observation of at least 3-4 hours in the hospital to ensure stability before discharge. Patients whose symptoms worsen or fail to improve with this treatment may require hospitalization for continued monitoring and further intervention.

For patients with severe respiratory distress, supplemental oxygen is administered using the "blow-by" method to avoid agitation that may be caused by nasal cannulas or masks. Agitation can exacerbate symptoms, including stridor, and worsen the obstruction. Intubation is rarely required in croup but may be necessary in approximately 0.2% of cases if the child progresses to respiratory failure. When intubation is necessary, an endotracheal tube (ETT) that is one-half size smaller than usual for the child's age or size should be used to account for the subglottic swelling. Intubation is indicated in cases of progressive respiratory failure with severe retractions, fatigue, central cyanosis, or when oxygenation cannot be maintained despite other interventions.

Steroids and Epinephrine in Croup Management

Corticosteroids, particularly dexamethasone, are the cornerstone of treatment for croup, regardless of severity. Studies have shown that even in mild croup, a single dose of dexamethasone improves symptom resolution, decreases the likelihood of returning to medical care, and reduces the length of hospital stay in more severe cases. While dexamethasone is the most widely used corticosteroid, budesonide is sometimes administered via nebulization, although it is generally considered less effective than dexamethasone for improving symptom scores. There is no significant difference in readmission rates between the two drugs.

Nebulized epinephrine is reserved for moderate to severe croup and provides quick relief from airway obstruction through its vasoconstrictive effects, reducing subglottic edema. The use of racemic epinephrine is common, but studies have shown that L-epinephrine can be more effective at two hours due to its longer duration of action. Children who receive nebulized epinephrine require close observation for several hours because the effects can wear off, leading to a return of airway obstruction. If symptoms do not recur within four hours of observation, the child may be discharged with instructions for close follow-up.

Oxygen, Steam, and Other Therapies

Supplemental oxygen is provided when the child exhibits signs of hypoxia, such as low oxygen saturation or cyanosis. The "blow-by" oxygen method is preferred over masks or nasal cannulas because it causes less agitation, which could exacerbate symptoms. Although humidified air and hot steam have been historically used to treat croup, studies have demonstrated no significant clinical benefit, and they are no longer recommended as standard treatments. Cough medicines, such as those containing dextromethorphan or guaifenesin, are discouraged as they offer little benefit and could potentially worsen respiratory symptoms or cause unwanted side effects.

Antibiotics are generally not indicated for croup because the illness is viral in most cases. However, if there is suspicion of a secondary bacterial infection, such as bacterial tracheitis or pneumonia, broad-spectrum antibiotics such as vancomycin and cefotaxime are recommended. In rare instances where croup is associated with influenza A or B, antiviral medications like neuraminidase inhibitors may be administered.